Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis.

Despite evidence for heritable variation in cannabis involvement and the discovery of cannabinoid receptors and their endogenous ligands, no consistent patterns have emerged from candidate endocannabinoid (eCB) genetic association studies of cannabis involvement. Given interactions between eCB and stress systems and associations between childhood stress and cannabis involvement, it may be important to consider childhood adversity in the context of eCB-related genetic variation. We employed a system-level gene-based analysis of data from the Comorbidity and Trauma Study (N = 1,558) to examine whether genetic variation in six eCB genes (anabolism: DAGLA, DAGLB, NAPEPLD; catabolism: MGLL, FAAH; binding: CNR1; SNPs N = 65) and childhood sexual abuse (CSA) predict cannabis dependence symptoms. Significant interactions with CSA emerged for MGLL at the gene level (p = .009), and for rs604300 within MGLL (ΔR2 = .007, p < .001), the latter of which survived SNP-level Bonferroni correction and was significant in an additional sample with similar directional effects (N = 859; ΔR2 = .005, p = .026). Furthermore, in a third sample (N = 312), there was evidence that rs604300 genotype interacts with early life adversity to predict threat-related basolateral amygdala habituation, a neural phenotype linked to the eCB system and addiction (ΔR2 = .013, p = .047). Rs604300 may be related to epigenetic modulation of MGLL expression. These results are consistent with rodent models implicating 2-arachidonoylglycerol (2-AG), an endogenous cannabinoid metabolized by the enzyme encoded by MGLL, in the etiology of stress adaptation related to cannabis dependence, but require further replication.

[1]  Kent E Hutchison,et al.  Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes. , 2008, Addiction.

[2]  D. Piomelli,et al.  The endocannabinoid system in brain reward processes , 2008, British journal of pharmacology.

[3]  M. Stein,et al.  The Childhood Trauma Questionnaire in a Community Sample: Psychometric Properties and Normative Data , 2001, Journal of traumatic stress.

[4]  Amit Bernstein,et al.  Posttraumatic stress and marijuana use coping motives: the mediating role of distress tolerance. , 2011, Journal of anxiety disorders.

[5]  T. Ramikie,et al.  Endocannabinoid signaling in the amygdala: anatomy, synaptic signaling, behavior, and adaptations to stress , 2012, Neuroscience.

[6]  Leyu Shi,et al.  Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice , 2008, Neuropharmacology.

[7]  Ting Wang,et al.  Exploring long-range genome interactions using the WashU Epigenome Browser , 2013, Nature Methods.

[8]  Matthew C. Keller,et al.  Gene × Environment Interaction Studies Have Not Properly Controlled for Potential Confounders: The Problem and the (Simple) Solution , 2014, Biological Psychiatry.

[9]  P. Sullivan,et al.  Increased risk of major depression by childhood abuse is not modified by CNR1 genotype , 2013, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics.

[10]  L. Petrocellis,et al.  An introduction to the endocannabinoid system: from the early to the latest concepts , 2009 .

[11]  Stephanie E. Afful,et al.  Drug use and dependence in cocaine dependent subjects, community-based individuals, and their siblings. , 2008, Drug and alcohol dependence.

[12]  W. Miller,et al.  Concomitance between childhood sexual and physical abuse and substance use problems. A review. , 2002, Clinical psychology review.

[13]  S. Floresco,et al.  Suppression of Amygdalar Endocannabinoid Signaling by Stress Contributes to Activation of the Hypothalamic-Pituitary-Adrenal Axis , 2009, Neuropsychopharmacology.

[14]  Laura J. Bierut,et al.  A genome-wide association study of alcohol dependence , 2010, Proceedings of the National Academy of Sciences.

[15]  M. Pompili,et al.  Factorial validity of the Childhood Trauma Questionnaire in Italian psychiatric patients , 2016, Psychiatry Research.

[16]  J. Hardy,et al.  Whole genome expression as a quantitative trait. , 2009, Biochemical Society transactions.

[17]  W. Tormey.  Adverse health effects of non-medical cannabis use , 2010, The Lancet.

[18]  Y. Nikolova,et al.  Multilocus Genetic Profile for Dopamine Signaling Predicts Ventral Striatum Reactivity , 2011, Neuropsychopharmacology.

[19]  A. Hariri,et al.  Mineralocorticoid receptor Iso/Val (rs5522) genotype moderates the association between previous childhood emotional neglect and amygdala reactivity. , 2012, The American journal of psychiatry.

[20]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[21]  Joseph P. Schacht,et al.  Intermediate cannabis dependence phenotypes and the FAAH C385A variant: an exploratory analysis , 2009, Psychopharmacology.

[22]  C. Sripada,et al.  Cannabinoid facilitation of fear extinction memory recall in humans , 2013, Neuropharmacology.

[23]  D. Piomelli.  The molecular logic of endocannabinoid signalling , 2003, Nature Reviews Neuroscience.

[24]  K. Kendler,et al.  PATHWAY BASED ANALYSIS OF GENOTYPES IN RELATION TO ALCOHOL DEPENDENCE , 2011, The Pharmacogenomics Journal.

[25]  S. Cherny,et al.  A genome-wide scan for loci influencing adolescent cannabis dependence symptoms: evidence for linkage on chromosomes 3 and 9. , 2007, Drug and alcohol dependence.

[26]  A. Agrawal,et al.  Candidate genes for cannabis use disorders: findings, challenges and directions. , 2009, Addiction.

[27]  Ivan Smirnov,et al.  Epigenomic annotation of genetic variants using the Roadmap Epigenome Browser , 2015, Nature Biotechnology.

[28]  B. Grant,et al.  Childhood adversity moderates the effect of ADH1B on risk for alcohol‐related phenotypes in Jewish Israeli drinkers , 2015, Addiction biology.

[29]  Jonathan Flint,et al.  Candidate and non-candidate genes in behavior genetics , 2013, Current Opinion in Neurobiology.

[30]  David Haussler,et al.  The Human Epigenome Browser at Washington University , 2011, Nature Methods.

[31]  N. Martin,et al.  Childhood sexual abuse and risks for licit and illicit drug-related outcomes: a twin study , 2006, Psychological Medicine.

[32]  R. Nicoll,et al.  Endocannabinoid Signaling in the Brain , 2002, Science.

[33]  A. Lichtman,et al.  The Selective Cannabinoid Antagonist SR 141716A Blocks Cannabinoid-Induced Antinociception in Rats , 1997, Pharmacology Biochemistry and Behavior.

[34]  T. Hergueta,et al.  The mini international neuropsychiatric interview , 1998, European Psychiatry.

[35]  J. Bains,et al.  Functional Interactions between Stress and the Endocannabinoid System: From Synaptic Signaling to Behavioral Output , 2010, The Journal of Neuroscience.

[36]  Matthew C Keller,et al.  A critical review of the first 10 years of candidate gene-by-environment interaction research in psychiatry. , 2011, The American journal of psychiatry.

[37]  Carson C Chow,et al.  Second-generation PLINK: rising to the challenge of larger and richer datasets , 2014, GigaScience.

[38]  Ursula S. Myers,et al.  Individual and Additive Effects of the CNR1 and FAAH Genes on Brain Response to Marijuana Cues , 2010, Neuropsychopharmacology.

[39]  B. Gorzalka,et al.  Increased sensitivity to restraint stress and novelty-induced emotionality following long-term, high dose cannabinoid exposure , 2006, Psychoneuroendocrinology.

[40]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[41]  Christina N. Lessov-Schlaggar,et al.  The genetics of addiction—a translational perspective , 2012, Translational Psychiatry.

[42]  Sarah E. Medland,et al.  A Quantitative-Trait Genome-Wide Association Study of Alcoholism Risk in the Community: Findings and Implications , 2011, Biological Psychiatry.

[43]  A. Lichtman,et al.  Inhibition of monoacylglycerol lipase reduces nicotine withdrawal , 2015, British journal of pharmacology.

[44]  Janet B W Williams.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[45]  N. Martin,et al.  Cannabinoid receptor genotype moderation of the effects of childhood physical abuse on anhedonia and depression. , 2012, Archives of general psychiatry.

[46]  M. Gonthier,et al.  The endocannabinoid system: its roles in energy balance and potential as a target for obesity treatment. , 2010, The international journal of biochemistry & cell biology.

[47]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[48]  J. Os,et al.  [18F]MK‐9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users , 2015, Addiction biology.

[49]  A. Lichtman,et al.  Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents. , 2014, European journal of pharmacology.

[50]  Sarah E Medland,et al.  Genetic and environmental influences on cannabis use initiation and problematic use: a meta-analysis of twin studies. , 2010, Addiction.

[51]  D. Boan,et al.  Childhood sexual abuse. , 1994, Southern medical journal.

[52]  Kai Wang,et al.  Pathway-based approaches for analysis of genomewide association studies. , 2007, American journal of human genetics.

[53]  Jason H. Moore,et al.  Pathway analysis of genomic data: concepts, methods, and prospects for future development. , 2012, Trends in genetics : TIG.

[54]  Sachin Patel,et al.  Reversible Gating of Endocannabinoid Plasticity in the Amygdala by Chronic Stress: A Potential Role for Monoacylglycerol Lipase Inhibition in the Prevention of Stress-Induced Behavioral Adaptation , 2011, Neuropsychopharmacology.

[55]  M. Egan,et al.  Serotonin Transporter Genetic Variation and the Response of the Human Amygdala , 2002, Science.

[56]  Scott F. Saccone,et al.  An autosomal linkage scan for cannabis use disorders in the nicotine addiction genetics project. , 2008, Archives of general psychiatry.

[57]  B. McEwen,et al.  Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[58]  N. Wray,et al.  Association of OPRD1 polymorphisms with heroin dependence in a large case‐control series , 2014, Addiction biology.

[59]  Phillip S. Kott,et al.  NATIONAL SURVEY ON DRUG USE AND HEALTH A COMPARISON OF VARIANCE ESTIMATION METHODS FOR REGRESSION ANALYSES WITH THE MENTAL HEALTH SURVEILLANCE STUDY CLINICAL SAMPLE , 2017 .

[60]  H. Long,et al.  Participation of endocannabinoids in rapid suppression of stress responses by glucocorticoids in neonates , 2013, Neuroscience.

[61]  R. McLaughlin,et al.  Endogenous cannabinoid signaling is essential for stress adaptation , 2010, Proceedings of the National Academy of Sciences.

[62]  M. Weiss,et al.  Adolescent chronic mild stress alters hippocampal CB1 receptor-mediated excitatory neurotransmission and plasticity , 2013, Neuroscience.

[63]  A. Goldstein,et al.  Child maltreatment and marijuana problems in young adults: examining the role of motives and emotion dysregulation. , 2014, Child abuse & neglect.

[64]  D. Yurgelun-Todd,et al.  Altered affective response in marijuana smokers: an FMRI study. , 2009, Drug and alcohol dependence.

[65]  P. Sham,et al.  The future of association studies: gene-based analysis and replication. , 2004, American journal of human genetics.

[66]  B. Gorzalka,et al.  The endocannabinoid system and the treatment of mood and anxiety disorders. , 2009, CNS & neurological disorders drug targets.

[67]  W. Cullinan,et al.  Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. , 2004, Endocrinology.

[68]  N. Volkow,et al.  Neurocircuitry of Addiction , 2010, Neuropsychopharmacology.

[69]  K. Bucholz,et al.  The association between cannabis abuse and dependence and childhood physical and sexual abuse: evidence from an offspring of twins design. , 2008, Addiction.

[70]  Annchen R Knodt,et al.  Basal forebrain moderates the magnitude of task-dependent amygdala functional connectivity. , 2015, Social cognitive and affective neuroscience.

[71]  J. Rabe-Jabłońska,et al.  [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders]. , 1993, Psychiatria polska.

[72]  B. Cravatt,et al.  Dual Inhibition of Endocannabinoid Catabolic Enzymes Produces Enhanced Antiwithdrawal Effects in Morphine-Dependent Mice , 2013, Neuropsychopharmacology.

[73]  M. First,et al.  Structured clinical interview for DSM-IV axis II personality disorders : SCID-II , 1997 .

[74]  Daniel L. Koller,et al.  Alcoholism susceptibility loci: confirmation studies in a replicate sample and further mapping. , 2000, Alcoholism, clinical and experimental research.

[75]  M. Jaber,et al.  Early exposure to environmental enrichment alters the expression of genes of the endocannabinoid system , 2011, Brain Research.

[76]  D. Bernstein,et al.  Childhood Trauma Questionnaire: A retrospective self-report manual , 1998 .

[77]  J. Briere,et al.  Childhood Sexual Abuse , 1993 .

[78]  Frank Dudbridge,et al.  Detecting multiple associations in genome-wide studies , 2006, Human Genomics.

[79]  V. Marzo.  Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight , 2010, Nature Neuroscience.

[80]  S. Purcell,et al.  Family-based association study of lithium-related and other candidate genes in bipolar disorder. , 2008, Archives of general psychiatry.

[81]  D. Nomura,et al.  Blockade of Endocannabinoid Hydrolytic Enzymes Attenuates Precipitated Opioid Withdrawal Symptoms in Mice , 2011, Journal of Pharmacology and Experimental Therapeutics.

[82]  A. Caspi,et al.  Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity , 2013, Molecular Psychiatry.

[83]  H. Hakonarson,et al.  Analysing biological pathways in genome-wide association studies , 2010, Nature Reviews Genetics.

[84]  J. Peters,et al.  Extinction circuits for fear and addiction overlap in prefrontal cortex. , 2009, Learning & memory.

[85]  T. Bisogno.  Endogenous Cannabinoids: Structure and Metabolism , 2008, Journal of neuroendocrinology.

[86]  N. Wray,et al.  ANKK1, TTC12, and NCAM1 polymorphisms and heroin dependence: importance of considering drug exposure. , 2013, JAMA psychiatry.

[87]  J. Nurnberger,et al.  A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA. , 1994, Journal of studies on alcohol.

[88]  Daniel S Pine,et al.  Sensation seeking and the aversive motivational system. , 2005, Emotion.

[89]  L J Horwood,et al.  Childhood sexual abuse and psychiatric disorder in young adulthood: II. Psychiatric outcomes of childhood sexual abuse. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[90]  K. Kendler,et al.  Childhood sexual abuse and adult psychiatric and substance use disorders in women: an epidemiological and cotwin control analysis. , 2000, Archives of general psychiatry.

[91]  J. Woodward,et al.  A review of the interactions between alcohol and the endocannabinoid system: implications for alcohol dependence and future directions for research. , 2012, Alcohol.

[92]  Y. Nikolova,et al.  Stress-related anhedonia is associated with ventral striatum reactivity to reward and transdiagnostic psychiatric symptomatology , 2015, Psychological Medicine.

[93]  P. Ekman,et al.  Unmasking the face : a guide to recognizing emotions from facial clues , 1975 .

[94]  M. Stein,et al.  Factorial validity of the Childhood Trauma Questionnaire in men and women , 2001, Depression and anxiety.

[95]  A. Pastor,et al.  Differential Role of Anandamide and 2-Arachidonoylglycerol in Memory and Anxiety-like Responses , 2011, Biological Psychiatry.

[96]  L. Iversen,et al.  Cannabinoids: a real prospect for pain relief? , 2002, Current opinion in pharmacology.

[97]  S. File,et al.  Endocannabinoid system and stress and anxiety responses , 2005, Pharmacology Biochemistry and Behavior.

[98]  C. Blanco,et al.  Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). , 2011, Drug and alcohol dependence.

[99]  M. Ware,et al.  Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials , 2015, Journal of Neuroimmune Pharmacology.

[100]  R. Bonsall,et al.  Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. , 2000, JAMA.

[101]  B. McEwen,et al.  Amygdala FAAH and anandamide: mediating protection and recovery from stress. , 2013, Trends in pharmacological sciences.

[102]  Jörg Fliege,et al.  Machine learning approaches for the discovery of gene-gene interactions in disease data , 2013, Briefings Bioinform..

[103]  J. Long,et al.  Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay , 2011, Pharmacology Biochemistry and Behavior.

[104]  K. Mackie,et al.  Effect of social isolation on CB1 and D2 receptor and fatty acid amide hydrolase expression in rats , 2008, Neuroscience.

[105]  Wayne Hall,et al.  Extent of illicit drug use and dependence, and their contribution to the global burden of disease , 2012, The Lancet.

[106]  V. Marzo,et al.  The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation. , 2009, Pharmacological research.

[107]  K. Mackie,et al.  Repeated Homotypic Stress Elevates 2-Arachidonoylglycerol Levels and Enhances Short-Term Endocannabinoid Signaling at Inhibitory Synapses in Basolateral Amygdala , 2009, Neuropsychopharmacology.

[108]  L. Degenhardt,et al.  Sex differences amongst dependent heroin users: histories, clinical characteristics and predictors of other substance dependence. , 2011, Addictive behaviors.

[109]  Scott F. Saccone,et al.  Novel genes identified in a high-density genome wide association study for nicotine dependence. , 2007, Human molecular genetics.

[110]  M. Angstadt,et al.  Cannabinoid Modulation of Amygdala Reactivity to Social Signals of Threat in Humans , 2008, The Journal of Neuroscience.

[111]  P. Holmans.  Statistical methods for pathway analysis of genome-wide data for association with complex genetic traits. , 2010, Advances in genetics.

[112]  P. Visscher,et al.  A versatile gene-based test for genome-wide association studies. , 2010, American journal of human genetics.

[113]  A. Hayes.  Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach , 2013 .

[114]  Avshalom Caspi,et al.  Gene–environment interactions in psychiatry: joining forces with neuroscience , 2006, Nature Reviews Neuroscience.

[115]  D. Piomelli,et al.  Endogenous Cannabinoid Signaling , 1998, Neurobiology of Disease.

[116]  M. Feldner,et al.  Marijuana use among traumatic event-exposed adolescents: posttraumatic stress symptom frequency predicts coping motivations for use. , 2012, Addictive behaviors.

[117]  Brendan P. Zietsch,et al.  No association of candidate genes with cannabis use in a large sample of Australian twin families , 2012, Addiction biology.

[118]  J. Long,et al.  Dual fatty acid amide hydrolase and monoacylglycerol lipase blockade produces THC-like Morris water maze deficits in mice. , 2012, ACS chemical neuroscience.

[119]  B. Grant,et al.  Cannabis use disorders in the USA: prevalence, correlates and co-morbidity , 2006, Psychological Medicine.

[120]  F. Pamplona,et al.  A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: Potential extinction enhancers , 2013, Neuropharmacology.

[121]  L. Bierut,et al.  DSM-5 cannabis use disorder: a phenotypic and genomic perspective. , 2014, Drug and alcohol dependence.

[122]  Andrew F. Hayes,et al.  Computational procedures for probing interactions in OLS and logistic regression: SPSS and SAS implementations , 2009, Behavior research methods.

[123]  Deepak L. Bhatt,et al.  Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial , 2010, The Lancet.

[124]  T. Bisogno,et al.  The endocannabinoid signalling system: Biochemical aspects , 2005, Pharmacology Biochemistry and Behavior.

[125]  B. Grant,et al.  Trauma exposure, posttraumatic stress disorder and risk for alcohol, nicotine, and marijuana dependence in Israel. , 2014, Comprehensive psychiatry.

[126]  S. Eisenstein,et al.  Social isolation and chronic handling alter endocannabinoid signaling and behavioral reactivity to context in adult rats , 2010, Neuroscience.

[127]  J. Hardy,et al.  Genotypic analysis of gene expression in the dissection of the aetiology of complex neurological and psychiatric diseases. , 2009, Briefings in functional genomics & proteomics.

[128]  Thomas E. Nichols,et al.  Common genetic variants influence human subcortical brain structures , 2015, Nature.

[129]  F. Kauffmann,et al.  Candidate gene–environment interactions , 2010, Journal of Epidemiology & Community Health.

[130]  R. Peters,et al.  Rimonabant: obituary for a wonder drug , 2010, The Lancet.

[131]  P. Ekman.  Unmasking The Face , 1975 .

[132]  V. Di Marzo,et al.  An introduction to the endocannabinoid system: from the early to the latest concepts. , 2009, Best practice & research. Clinical endocrinology & metabolism.

[133]  J. Long,et al.  Inhibitors of Endocannabinoid-Metabolizing Enzymes Reduce Precipitated Withdrawal Responses in THC-Dependent Mice , 2009, The AAPS Journal.

[134]  M. Newcomb,et al.  Development and validation of a brief screening version of the Childhood Trauma Questionnaire. , 2003, Child abuse & neglect.

[135]  Scott F. Saccone,et al.  A genome‐wide association study of DSM‐IV cannabis dependence , 2011, Addiction biology.

[136]  J. Rice,et al.  Genome-wide search for genes affecting the risk for alcohol dependence. , 1998, American journal of medical genetics.

[137]  M. Hill,et al.  Age of stress exposure modulates the immediate and sustained effects of repeated stress on corticolimbic cannabinoid CB1 receptor binding in male rats , 2013, Neuroscience.

[138]  V. Di Marzo.  The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation. , 2009, Pharmacological research.

[139]  R. Maldonado,et al.  Cannabinoid Addiction: Behavioral Models and Neural Correlates , 2002, The Journal of Neuroscience.

[140]  J. Herman.  Neural control of chronic stress adaptation , 2013, Front. Behav. Neurosci..

[141]  Yun Liu,et al.  Association between DRD2/ANKK1 TaqIA polymorphism and common illicit drug dependence: evidence from a meta-analysis. , 2015, Human immunology.

[142]  K. Kendler,et al.  Candidate Gene–Environment Interaction Research , 2015, Perspectives on psychological science : a journal of the Association for Psychological Science.

[143]  L. Wise,et al.  Hippocampal CB1 receptors mediate the memory impairing effects of Δ9-tetrahydrocannabinol , 2009, Neuropsychopharmacology.

[144]  Chen Li,et al.  Role of the endocannabinoid system in food intake, energy homeostasis and regulation of the endocrine pancreas. , 2011, Pharmacology & therapeutics.

[145]  Johnny S. H. Kwan,et al.  GATES: a rapid and powerful gene-based association test using extended Simes procedure. , 2011, American journal of human genetics.